FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Celgene Corporation
Industry / private company
Location:
Summit, NJ, United States (USA) (US)
ISNI
: -
Publications
(23)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis (2020)
Danese S, Neurath M, Kopoń A, Zakko SF, Simmons TC, Fogel R, Siegel CA, et al.
Journal article
Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials (2020)
Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, et al.
Journal article
Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs (2020)
Zhang M, Haughey M, Wang NY, Blease K, Kapoun AM, Couto S, Belka I, et al.
Journal article
Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis (2019)
Kavanaugh A, Gladman DD, Edwards CJ, Schett G, Guerette B, Delev N, Teng L, et al.
Journal article
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis (2019)
Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies F, Rosenthal A, et al.
Journal article
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma (2018)
Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, Rosenthal A, et al.
Journal article
Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study (2018)
Danese S, Neurath M, Kopon A, Zakko S, Simmons T, Fogel R, Maccarone J, et al.
Conference contribution
5-YEAR EFFICACY AND SAFETY OF APREMILAST TREATMENT IN SUBJECTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THE PALACE STUDIES (2018)
Kavanaugh A, Gladman DD, Edwards CJ, Schett G, Guerette B, Delev N, Teng L, et al.
Conference contribution
Durability of apremilast response through 5 years of treatment in subjects with psoriatic arthritis (2018)
Kavanaugh A, Gladman DD, Gomez-Reino JJ, Hall S, Lespessailles E, Mease PJ, Schett G, et al.
Conference contribution
LONG-TERM (156-WEEK) IMPROVEMENTS IN DACTYLITIS AND ENTHESITIS WITH APREMILAST INPSORIATIC ARTHRITIS SUBJECTS: ANALYSIS OF A LARGE, POOLED PALACE 1-3 DATABASE (2018)
Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al.
Conference contribution
‹
1
2
3
›